Cartesian Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Cartesian Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cartesian Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cartesian Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $92k | 15k | 6.20 |
| 2025-12-31 | $168k | 23k | 7.21 |
| 2025-09-30 | $194k | 19k | 10.22 |
| 2025-06-30 | $304k | 29k | 10.39 |
| 2024-12-31 | $435k | 24k | 17.91 |
| 2024-09-30 | $355k | 22k | 16.12 |
| 2024-06-30 | $196k | 7.2k | 27.01 |